Scholars@Duke publication: Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.

Publication , Journal Article

Li, Q; Liu, B; Chao, H-P; Ji, Y; Lu, Y; Mehmood, R; Jeter, C; Chen, T; Moore, JR; Li, W; Liu, C; Rycaj, K; Tracz, A; Kirk, J; Xiong, J ...

Published in: Nat Commun

June 4, 2020

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Nat Commun

2041-1723

June 4, 2020

2895

England

APA

Chicago

ICMJE

MLA

NLM

Li, Q., Liu, B., Chao, H.-P., Ji, Y., Lu, Y., Mehmood, R., … Tang, D. G. (2020). Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun, 11(1), 2895. https://doi.org/10.1038/s41467-020-16615-9

Li, Qiuhui, Bigang Liu, Hsueh-Ping Chao, Yibing Ji, Yue Lu, Rashid Mehmood, Collene Jeter, et al. “Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.” Nat Commun 11, no. 1 (June 4, 2020): 2895. https://doi.org/10.1038/s41467-020-16615-9.

Li, Qiuhui, et al. “Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.” Nat Commun, vol. 11, no. 1, June 2020, p. 2895. Pubmed, doi:10.1038/s41467-020-16615-9.

Li Q, Liu B, Chao H-P, Ji Y, Lu Y, Mehmood R, Jeter C, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG. Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun. 2020 Jun 4;11(1):2895.

Nat Commun

2041-1723

June 4, 2020

2895

England